tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Similar Stocks

Compare
455 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Relay Therapeutics
$2.72
$461.10M
-67.23%
8 Buy
1 Hold
0 Sell
Strong Buy
Exelixis
$36.70
$10.27B
20.71
55.44%
10 Buy
7 Hold
0 Sell
Moderate Buy
Incyte
$60.60
$11.73B
223.45
6.37%
6 Buy
11 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$492.69
$126.52B
17.87%
16 Buy
10 Hold
1 Sell
Moderate Buy
Fate Therapeutics
$0.85
$97.33M
-88.43%
4 Buy
8 Hold
0 Sell
Moderate Buy
Blueprint Medicines
$88.72
$5.67B
-6.47%
14 Buy
4 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RLAY
Relay Therapeutics
2.72
-5.30
-66.08%
EXEL
Exelixis
36.70
13.02
54.98%
INCY
Incyte
60.60
3.96
6.99%
VRTX
Vertex Pharmaceuticals
492.69
72.21
17.17%
FATE
Fate Therapeutics
0.85
-6.23
-87.99%
BPMC
Blueprint Medicines
88.72
-7.70
-7.99%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis